Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the pharma industry. This time, you get to discover 5 hand-picked prescription digital therapeutics solutions.
Global Startup Heat Map highlights 5 Top Prescription Digital Therapeutics Solutions out of 57
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence-powered StartUs Insights Discovery Platform, covering 2.093.000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 57 exemplary startups & scaleups we analyzed for this research. Further, it highlights 5 prescription digital therapeutics startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these 5 startups & scaleups in this report. For insights on the other 52 prescription digital therapeutics solutions, get in touch.
Click to download
Limbix offers Digital Mental Health Platform
Mental health management is an essential aspect to curb depression in adolescents. Amidst pandemic, there is an emerging need for virtual or digital healthcare solutions for treating mental health disorders. As many clinics have reduced capacity or closed practice, digital tools address the gap for patients. Clinician-prescribed virtual care platforms enable patients to continue their course of treatment and improve their well-being remotely.
US-based startup Limbix develops prescription digital therapeutic solutions for young adults. The platform is designed to offer cognitive behavioral therapy-based programs. Limbix is currently conducting a full-remote randomized control clinical trial for its therapeutic solution. The preliminary results show a reduction in depressive symptoms in prescribed adolescents compared to the control group, offered with psycho-educational tools.
Neuroglee Therapeutics develops Digital Therapeutics for Neurodegenerative Diseases
The onset of neurodegenerative disease and course of treatment affects the patients physically and emotionally. Thus, proper stress and behavior management is an important aspect for patients with neurodegenerative diseases. Conventional treatment regimes don’t always include tailored tools to support clinical, lifestyle issues, and disease management. However, digital therapeutics address this need and improve adherence to treatment and self-management, reducing stress and anxiety.
Singaporean startup Neuroglee Therapeutics offers prescription digital therapeutics for patients with Alzheimer’s disease. The startup’s proprietary AI-based software, NG-001, monitors and continuously tracks the patient’s digital biomarkers. NG-001 monitors cognitive health using advanced biosensors and intuitive digital tools. Using the baseline data, the platform provides mobile-based dynamic therapeutic intervention.
daVinci Digital Therapeutics provides Digital Therapy for Substance Abuse
Substance abuse rehabilitation requires continuous monitoring and patient engagement. Advanced digital tools provide better assessment and understanding of substance use disorders (SUDs). Prescription digital therapeutics extend the treatment of SUDs outside the rehabilitation facilities. Such tools leverage digital biomarkers that provide insights into the daily life of the patient with data on de-addiction progress.
Italian startup daVinci Digital Therapeutics develops evidence-based prescription digital therapeutics to treat substance abuse disorders and other chronic illnesses. The startup’s solution is based on digital biotechnology and functions as a therapeutic either stand-alone or in combination with an antidepressant drug. daVinci is also working on an AI-based platform for mental health disorders that features a digital assistant with natural language processing (NLP) capabilities.
metaMe Health works on Digital Therapeutics for Gastrointestinal Conditions
Gastrointestinal disorders require monitoring and timely intervention in terms of diet intake, pharmaceutical supplement, and alteration in therapeutic parameters. A gap in monitoring the diet of patients with digestive disorders often leads to preventable hospitalizations. Digital therapeutics enable behavioral treatment and improve adherence to medications and diet. Prescription digital therapeutics act as a standalone treatment or in combination with other pharmaceuticals to effectively reduce digestive ailments, including irritable bowel syndrome (IBS), peptic ulcer disease (PUD), and gastroesophageal reflux disease (GERD), among others.
US-based startup metaMe Health develops FDA-certified prescription digital therapeutic solutions for gastrointestinal disorders. The startup’s IBS software platform focuses on behavioral treatment for patients with existing conditions like bloating, diarrhea, and abdominal pain. The startup is investigating it as a standalone treatment regimen as well as in combination with existing pharmaceuticals.
Theranica Bio-Electronics specializes in Prescription Digital Therapeutics for Pain Management
Some people experience constant pain from migraines or chronic illnesses, which affect their day-to-day life and activities. Analgesics are a common solution to contain the pain. However, analgesic drugs have various side effects including itchiness, upset stomach, and drowsiness. Digital therapeutics offer a drug-free alternative for 24/7 pain management.
Israeli startup Theranica Bio-Electronics offers clinically proven prescription digital therapeutics for pain management. The startup’s therapeutic solution is based on electrical neuromodulation and it utilizes an inhibition mechanism known as conditioned pain modulation (CPM). It combines wearable and a digital platform for effective pain management. The startup’s wearable solution, Nerivio, modulates pain by stimulating upper arm peripheral nerves, releasing neurotransmitters that inhibit pain sensation.
Discover more Pharma startups
Pharma startups such as the examples highlighted in this report focus on prescription digital therapeutics for neurodegenerative diseases, pain management, and gastrointestinal conditions, as well as for mental health. While all of these technologies play a major role in advancing digital therapeutics, they only represent the tip of the iceberg. To explore more pharma technologies, simply get in touch to let us look into your areas of interest. For a more general overview, you can download our free Pharma Innovation Report to save your time and improve strategic decision-making.
